Joseph Larosa - Jul 2, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Jul 2, 2021
Transactions value $
-$4,023,224
Form type
4
Date filed
7/7/2021, 04:01 PM
Next filing
Aug 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1.79M +10K +75.86% $179.13 23.2K Jul 2, 2021 Direct F1
transaction REGN Common Stock Tax liability -$3.84M -6.6K -28.48% $582.20 16.6K Jul 2, 2021 Direct F1
transaction REGN Common Stock Sale -$1.97M -3.4K -20.49% $580.00 13.2K Jul 6, 2021 Direct F1
holding REGN Common Stock 3.19K Jul 2, 2021 2021 GRAT
holding REGN Common Stock 314 Jul 2, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -10K -20% $0.00 40K Jul 2, 2021 Common Stock 10K $179.13 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.